TruNativ is a Mumbai-based clean-label nutrition brand that sells protein, fibre, and sugar-reduction products for everyday health-conscious consumers. Its new TruNativ funding round brings in $30 million from OrbiMed Advisors LLC at a time when Indian nutrition shoppers still deal with confusing labels, processed formulas, and patchy access outside online channels. Founded in 2019 by Pranav Malhotra and Mamta Malhotra, the company now wants to turn a digital-first nutrition business into a much broader retail brand.
What is TruNativ and what does it sell?
TruNativ started with plant-based protein powders and has since widened into a larger nutrition portfolio that includes supplements built around protein intake, fibre, and sugar replacement. It sells through its own website and other ecommerce platforms. That puts it in the fast-growing D2C nutrition brand bucket rather than old-school pharmacy-led supplements.
The product pitch is pretty clear. TruNativ isn’t trying to be a hardcore bodybuilding label. It’s built more for mainstream consumers who want everyday nutrition fixes without the usual ingredient-list headache. Two of its strongest categories have been fibres and sugar replacers, which says a lot about where it sees demand in India’s wellness market.
The customer journey is simple. A buyer comes in with a need — more protein, less sugar, better digestion, or a cleaner daily nutrition add-on — and chooses a use-case-led product instead of decoding a dense sports supplement catalogue. That matters because a lot of supplement buying in India still feels like guesswork. TruNativ’s edge is less about tech and more about removing that confusion with transparent, everyday-use formats.
That positioning has kept expanding. Over time, the company moved beyond an early protein-led identity into a broader nutritional supplements line, and founder Pranav Malhotra said in 2023 that the brand planned to launch 15 new SKUs in a single quarter. That’s aggressive.
Who founded TruNativ and what traction has it built?
The founding story
TruNativ was founded in 2019 by Pranav Malhotra and Mamta Malhotra in Mumbai. Pranav Malhotra is founder and CEO, while Mamta Malhotra is cofounder. From day 1, the business was built around a direct idea: healthier food alternatives can’t stay niche if they’re hard to understand, hard to trust, or hard to fit into daily routines.
The brand’s identity matters here too. TruNativ talks about “clean-label” nutrition, and that phrase gets thrown around a lot. In practice, it usually means shorter ingredient lists and clearer formulations. Products also try to avoid the over-engineered feel of legacy supplement brands. For Indian consumers who’ve become more skeptical about artificial sweeteners and heavily processed wellness products, that’s a real positioning choice.
Traction and early signals
A few public signals show how it’s executing. In July 2023, TruNativ said it had generated $6 million in revenue in the first 3 years since inception and expected a 5x rise in FY24. At that point, 80% of sales came from online channels, while the remaining 20% came from offline retail through chains such as Nature’s Basket and Wellness Forever.
That split explains the current strategy better than any founder slogan could. The company already proved people will buy clean-label nutrition online. The harder part is building the same trust and repeat purchase behavior in physical retail, where shelf competition is brutal and consumer attention is short.
Inc42 currently lists TruNativ at 52 employees and categorizes the company at the Series B stage after the latest raise. For a nutrition startup that began with a narrower D2C product set, that’s a sign it’s no longer an experiment. It’s an operating brand with a scaled-up team and a more serious capital base.
How does the TruNativ funding round break down?
The new TruNativ funding round is worth $30 million, and OrbiMed Advisors LLC led it. OrbiMed is a global healthcare-focused investment firm. The deal includes both fresh primary capital for the company and secondary share sales by some early investors. That mix tells you two things at once: the business needs growth capital, and early backers are getting at least partial liquidity.
This isn’t TruNativ’s first outside backing. Rainmatter, the Zerodha-backed early-stage investment firm, invested ₹10 crore in November 2024. Before that, TruNativ raised an undisclosed seed round in April 2021. Public reporting from 2023 also showed Emami had taken a 19% stake in the parent company, giving TruNativ earlier strategic validation from a larger consumer player.
The new money is earmarked for offline distribution and product portfolio expansion. It will also fund faster growth in India and overseas. That’s a logical use of capital. Nutrition brands don’t become durable by winning online ads forever. They become durable when people can find them easily and buy them again without thinking too hard.
How does TruNativ compare with other nutrition brands?
TruNativ sits in a crowded part of India’s consumer internet market. It’s up against clean-food and supplement brands like The Whole Truth, OZiva, Wellbeing Nutrition, and sports-nutrition-heavy players such as MuscleBlaze. There’s also older competition — chemist shelves, legacy nutraceutical brands, and generic sugar-free or protein products that don’t exactly win on transparency.
Its differentiation is pretty specific. TruNativ isn’t only chasing gym users, and it isn’t selling itself as a medical nutrition company either. It’s building around everyday use cases: better protein intake, cleaner sugar alternatives, digestive support, and products that can fit normal households rather than only fitness subcultures. That middle ground is crowded. It’s also where the biggest consumer volume usually sits.
OrbiMed’s bet likely rests on that widening appeal. If TruNativ can move from an online-first wellness label into a recognizable omnichannel nutrition brand, it gets a lot more valuable. Repeatable consumer health habits tend to create sticky businesses when the brand earns trust early.
Why the TruNativ funding round matters for retail growth
This round matters because it changes the company’s next test.
Until now, TruNativ had already shown it could find customers online and stretch beyond a single product identity. What it hadn’t fully done was build serious offline muscle. That’s where the new capital comes in. More retail presence means more visibility and a shot at becoming a habitual purchase instead of an occasional digital reorder.
It also matters because of who wrote the check. OrbiMed isn’t a casual D2C tourist. It’s known for healthcare investing, so its entry suggests TruNativ is being viewed through a wider preventive-health lens, not just as another packaged-food startup. That doesn’t guarantee success. But it does suggest investors see nutrition and functional food as a longer-term healthcare adjacency, not a short-term trend.
There’s a quieter signal here too. Secondary share sales in the deal mean some early investors got partial exits without killing growth financing. That’s usually healthier than endless paper markups with no liquidity.
How big is India’s clean-label nutrition market?
The addressable market is big enough to justify ambition. IMARC estimates India’s nutritional supplements market reached $22.9 billion in 2025 and could grow to $58.8 billion by 2034, a CAGR of 10.7%. In a separate estimate, the India dietary supplements market stood at ₹201.46 billion in 2025 and is projected to hit ₹572.62 billion by 2034.
That growth isn’t happening by accident. Indian consumers are spending more on preventive health. Protein intake is becoming a mainstream conversation rather than a gym-only one. Ecommerce has made discovery easier for niche brands. Clean-label products also benefit from a broader trust shift: buyers want simpler ingredient stories, especially in categories tied to daily consumption and family health. IMARC’s 2026 nutraceutical outlook also flags rising demand for plant-based and clean-label products in India, which lines up with TruNativ’s pitch.
TruNativ has raised a lot of money for a brand that still has plenty to prove in offline retail. The next thing to watch isn’t whether it can launch more products. It’s whether the TruNativ funding round can turn a digital nutrition label into a real consumer brand with shelf power.
Read how Sarvam AI raised $234M in a Series B led by HCLTech to build Indian-language AI infrastructure, helping enterprises deploy voice, text, and document intelligence systems that work across local languages and real-world business workflows.
FAQ
- What is the latest TruNativ funding round?
TruNativ has raised $30 million in its latest round led by OrbiMed Advisors LLC. The transaction includes both primary capital for the company and secondary share sales by some early investors, which gives TruNativ new growth money while also creating liquidity for earlier backers. - What does TruNativ actually sell?
TruNativ sells clean-label nutrition products rather than a single hero supplement. Its range began with plant-based protein powders and expanded into broader nutritional supplements. Fibre and sugar replacers emerged as important categories in the brand’s earlier growth phase. - Who founded TruNativ?
TruNativ was founded in 2019 by Pranav Malhotra and Mamta Malhotra. Pranav Malhotra is founder and CEO, and the company was built in Mumbai around the idea of making healthier daily nutrition easier to trust and easier to use. - Is TruNativ in the supplements market or the consumer food market?
It sits across both, which is part of why investors may find it attractive. TruNativ operates as a D2C consumer brand, but it sells into the much larger nutrition, nutraceutical, and dietary supplements category — a market that IMARC estimates could expand sharply through 2034 in India.
Leave a Reply